CONMED Gross Profit 2010-2024 | CNMD

CONMED gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
CONMED Annual Gross Profit
(Millions of US $)
2023 $676
2022 $571
2021 $568
2020 $460
2019 $525
2018 $469
2017 $431
2016 $408
2015 $382
2014 $404
2013 $412
2012 $406
2011 $375
2010 $365
2009 $337
CONMED Quarterly Gross Profit
(Millions of US $)
2024-03-31 $172
2023-12-31 $182
2023-09-30 $168
2023-06-30 $171
2023-03-31 $155
2022-12-31 $132
2022-09-30 $152
2022-06-30 $152
2022-03-31 $136
2021-12-31 $156
2021-09-30 $142
2021-06-30 $141
2021-03-31 $128
2020-12-31 $136
2020-09-30 $134
2020-06-30 $72
2020-03-31 $119
2019-12-31 $142
2019-09-30 $130
2019-06-30 $131
2019-03-31 $121
2018-12-31 $133
2018-09-30 $111
2018-06-30 $116
2018-03-31 $110
2017-12-31 $124
2017-09-30 $103
2017-06-30 $105
2017-03-31 $100
2016-12-31 $107
2016-09-30 $101
2016-06-30 $102
2016-03-31 $98
2015-12-31 $102
2015-09-30 $94
2015-06-30 $93
2015-03-31 $92
2014-12-31 $104
2014-09-30 $96
2014-06-30 $101
2014-03-31 $103
2013-12-31 $111
2013-09-30 $95
2013-06-30 $103
2013-03-31 $103
2012-12-31 $107
2012-09-30 $98
2012-06-30 $100
2012-03-31 $101
2011-12-31 $96
2011-09-30 $91
2011-06-30 $91
2011-03-31 $96
2010-12-31 $91
2010-09-30 $89
2010-06-30 $94
2010-03-31 $92
2009-12-31 $96
2009-09-30 $88
2009-06-30 $77
2009-03-31 $76
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.078B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.372B 21.99
Becton Dickinson (BDX) United States $67.549B 19.11
Cardinal Health (CAH) United States $25.353B 14.50
West Pharmaceutical Services (WST) United States $23.461B 42.05
Cooper (COO) United States $18.251B 26.92
Align Technology (ALGN) United States $18.233B 35.20
Labcorp (LH) United States $17.408B 14.98
Henry Schein (HSIC) United States $8.743B 15.55
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Merit Medical Systems (MMSI) United States $4.726B 25.90
Patterson (PDCO) United States $2.274B 10.99
STAAR Surgical (STAA) United States $2.026B 77.79
Atrion (ATRI) United States $0.803B 42.87
Lifevantage (LFVN) United States $0.085B 10.97
Pro-Dex (PDEX) United States $0.065B 32.67
Biolase (BIOL) United States $0.004B 0.00